Read More Pharma Industry News Why BioAge Labs’ promising obesity drug trial of azelaprag came to an abrupt halt BioAge Labs, a clinical-stage biopharmaceutical company focused on metabolic disease research, has announced the discontinuation of its STRIDES… byPallavi MadhirajuDecember 7, 2024